Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease With Transjugular 3D Intracardiac Echocardiography Guidance Authors: Stormy Keppel, Arvind Kapila, Marcos Nores, Waqas Ghumman, Sajid Mirza, Luis Arcay, Mark Rothenberg, Sara Bierschenk, Christopher Hawk Published: 2026 ABSTRACT BackgroundTranscatheter tricuspid valve replacement (TTVR) with the EVOQUE system was the first Food and Drug Administration–approved TTVR therapy for clinical use in patients with symptomatic severe tricuspid regurgitation. Successful implantation is largely dependent on both fluoroscopic and transesophageal echocardiography (TEE) guidance. Imaging by TEE may be inadequate for confident and successful TTVR, which has led to adjunctive imaging with intracardiac echocardiography (ICE).Case SummaryWe present a unique case of TTVR with the EVOQUE system using transjugular 3-dimensional (3D) ICE guidance in symptomatic severe tricuspid regurgitation due to carcinoid syndrome in the setting of cardiogenic shock.DiscussionTransjugular 3D ICE is an effective adjunctive imaging modality for TTVR in patients who have inadequate imaging on TEE.Take-Home MessageA transjugular approach for 3D ICE offers an alternative route compared with transfemoral for real-time visualization of the tricuspid valve leaflets with no interference with the valve delivery system. History of Presentation An 81-year-old man with a medical history of hypertension, hypercholesterolemia, and diabetes mellitus presented to the hospital due to symptoms of dyspnea, abdominal distension, lower extremity swelling, and recurrent diarrhea for several weeks. He was admitted for acute decompensated heart failure in the setting of severe tricuspid regurgitation (TR) and moderate aortic stenosis (AS), diagnosed by transthoracic echocardiography (TTE) and a right heart catheterization (RHC). After he became more euvolemic, he was discharged from the hospital with follow-up at the valve clinic for assessment of his AS and TR. At his clinic visit, the patient was examined and his computed tomography transcatheter aortic valve replacement (TAVR) imaging reviewed. The team decided to admit him in the setting of acute decompensated heart failure with a presumptive diagnosis of carcinoid syndrome (primary small bowel with metastasis to the liver) leading to severe TR and cardiogenic shock. The diagnosis was confirmed with elevated serotonin levels (2,076 ng/mL). His course was complicated by ascites, pleural effusions, and cardiogenic shock. He required the initiation of dobutamine for inotrope-assisted diuresis, repeated paracentesis and thoracentesis, and an octreotide drip in the setting of carcinoid syndrome. After the patient became euvolemic and hemodynamically stable, he was evaluated for potential transcatheter tricuspid valve replacement (TTVR). Past Medical History The patient had a past medical history of hypertension, hyperlipidemia, and diabetes mellitus. Differential Diagnosis Possible conditions leading to the clinical presentation of this patient could be from the severe low-flow low-gradient AS or severe TR. Investigations On the initial admission, a TTE was performed and demonstrated moderate AS with a mean gradient of 25 mm Hg; however, with a dimensionless index of 0.16 suggesting severe AS. In the setting of a mildly reduced ejection fraction, an RHC with dobutamine was performed. The hemodynamics revealed elevated right-sided filling pressures, normal mean pulmonary artery pressure, and a low cardiac output consistent with cardiogenic shock. They also revealed a pre-dobutamine aortic valve mean gradient of 18.4 mm Hg and aortic valve area (AVA) of 0.77 cm2 and a post-dobutamine aortic valve mean gradient of 19.3 mm Hg and AVA of 0.97 cm2. The increase in cardiac output (CO) from 2.92 L/min to 3.46 L/min was driven entirely by chronotropy as the heart rate increased from 90 beats/min to 117 beats/min. The stroke volume index changed very little from 16.78 mL/beat/m2 to 15.32 mL/beat/m2 demonstrative of very poor contractile reserve. The increase in AVA that accompanied the increase in CO suggested moderate low-flow low-gradient AS, which was further supported by a calcium score of 1,708. Additional RHC findings are as follows: right atrium: 9/22/10 mm Hg, right ventricle: 32/7 mm Hg, pulmonary artery: 33/7/15 mm Hg, pulmonary capillary wedge pressure: 8 mm Hg, systemic vascular resistance: 1,669 dyn/s/cm−5, pulmonary artery pulsatility index: 2.6, right atrial pressure/pulmonary capillary wedge pressure: 1.25, transpulmonary pressure gradient: 7 mm Hg, pulmonary vascular resistance: 3.76 WU, right ventricular work stroke index: 1.46 g × m/m2/beat, CO: 2.92 L/min, and cardiac index: 1.51 L/min/m2. These hemodynamics revealed elevated right-sided filling pressures, normal mean pulmonary artery pressure, and a low CO consistent with cardiogenic shock. A left heart catheterization was also performed that demonstrated no obstructive coronary artery disease. Transesophageal echocardiography (TEE) was performed demonstrating torrential TR; however, both esophageal and transgastric views of the tricuspid valve (TV) leaflets were limited due to calcification of the aortic valve. Management The heart team convened to discuss this complex patient afflicted with a metastatic neuroendocrine tumor (NET) complicated by carcinoid syndrome and torrential TR leading to cardiogenic shock. After a discussion with oncology, it was deemed that the patient had a favorable life expectancy that would be beyond 1 year using medical therapy for treatment of the metastatic NET. Opinions varied among the heart team. Although most believed the TR to be the culprit lesion, others advocated treating the left-sided lesion first. Balloon aortic valvuloplasty (BAV) has proven to be an effective bridge to TAVR in patients who are critically ill and poor candidates.1 There was also concern that the TAVR prosthesis could further impair visualization of the TV, complicating TTVR. Ultimately, the decision was made to perform a BAV and to assess the patient's response clinically. If the patient were to improve, we would plan for eventual TAVR; however, if the patient failed to improve, we would plan to treat the culprit TV. Although transcatheter edge to edge repair could be advantageous in the setting of right-sided heart failure and poor right ventricular function, the leaflet morphology precluded use of this modality. TTVR, despite its challenges, would be the only option. BAV was performed using a 25-mm True Dilation balloon (minimum annular diameter), reducing the mean gradient of the aortic valve from 28 mm Hg (AVA 0.92 cm2) and to 19 mm Hg (AVA 0.87 cm2). This was considered a success, despite a relatively unchanged AVA. We attribute this to a transient decrease in CO following rapid pacing. Despite these efforts, the patient failed to improve, prompting plans for definitive TV replacement. Outcome and Follow-Up A TEE was performed preoperatively, and it demonstrated torrential TR (Figure 1). The visualization of the TV leaflets from the midesophageal view was suboptimal due to artifact from the calcified aortic valve (Video 1). Transgastric views were acquired that demonstrated the distinctive thickening and tethering of the carcinoid TV leaflets, but incomplete visualization of the septal leaflet (Video 2). To obtain complete visualization of the TV leaflets for confident TTVR, we decided to use 3-dimensional (3D) intracardiac echocardiography (ICE) (NUVISION J&J catheter).Figure 1Preoperative TEE FindingPreoperative TEE showing an apical 4-chamber view of the TV demonstrating severe TR. TEE = transesophageal echocardiography; TR = tricuspid regurgitation; TV = tricuspid valve. Preoperative TEE Finding Preoperative TEE showing an apical 4-chamber view of the TV demonstrating severe TR. TEE = transesophageal echocardiography; TR = tricuspid regurgitation; TV = tricuspid valve. The 3D ICE catheter is normally inserted via a transfemoral approach; however, we decided instead to insert the catheter via a transjugular approach, which provides the novelty for this case. Sterile access was obtained in the right internal jugular vein and the ICE catheter advanced under fluoroscopy into the high right atrium using a sterile glove. A sterile plastic sleeve was then advanced from the handle to the sheath so that the probe could be manipulated without needing sterility. There were no blind spots and images of the TV were obtained (Videos 3 and 4). A major advantage of the ICE catheter from the right internal jugular was the minimal manipulation required, as opposed to the manipulation that is required when using a TEE probe or even when the approach is through a femoral vein. While the procedure was conducted, the ICE catheter was placed in a probe holder (Figure 2), thereby freeing the imager for live multiplanar reconstruction.Figure 2Preprocedural Imaging SetupThe transjugular 3-dimensional ICE catheter is visualized well-seated within the sterile probe cover positioned at the head of the bed. ICE = intracardiac echocardiography. Preprocedural Imaging Setup The transjugular 3-dimensional ICE catheter is visualized well-seated within the sterile probe cover positioned at the head of the bed. ICE = intracardiac echocardiography. These efforts led to the successful implantation of the EVOQUE valve system of the TV (Videos 5A and 5B). After the procedure, the patient experienced an improvement of his symptoms and hemodynamic stability, which ultimately led to the discontinuation of inotrope therapy and initiation of guideline-directed medical therapy for management of his heart failure. The goal was to perform a possible TAVR in the near future; however, the response was incomplete, leading to multiple readmissions and failure to thrive in the setting of recurrent septic and cardiogenic shock. Ultimately, the patient and family chose palliative care and hospice. Discussion Carcinoid heart disease is often the result of NET metastasis to the liver. NET products (histamine, serotonin, hydroxyindoleacetic acid) secreted into the portal system are inactivated by the liver, but once tumor is present in the liver, these bioproducts enter the systemic circulation in an active state. These active bioproducts directly contact the cardiac valves, leading to the characteristic thickening and retraction of the TV leaflets, resulting in conditions such as tricuspid stenosis and regurgitation.2 This case demonstrates a patient with carcinoid syndrome who developed carcinoid heart disease with severe TR and pseudo-severe AS with cardiogenic shock. The AS was a separate entity of the carcinoid heart disease, as no intracardiac shunt was present on TEE. After shared decision making with the patient, the decision was made to perform a BAV and assess response. This led to improvement of the aortic mean gradient; however, the patient remained symptomatic and continued inotrope-assisted diuresis. In the absence of clinical improvement, we proceeded with TTVR. We did face a challenge when imaging the TV. It is often difficult to visualize the TV on TEE due to the anterior anatomical plane of the valve and acoustic shadowing.3 Common causes of acoustic shadowing include calcified aortic valves, mitral annular calcification, prosthetic valve implantations, cardiac implantable electronic devices, and lipomatous hypertrophy of the intra-atrial septum.4 Although the patient underwent a BAV, this did not improve the degree of calcification present on the valve, as it is not expected to, therefore the imaging of the TV remained difficult. The midesophageal and transgastric TEE views of the TV were limited from the acoustic shadowing of the calcified aortic valve. This made it imperative to use 3D ICE imaging as an adjunct to TEE for TTVR. Traditionally the 3D ICE catheter is inserted transfemorally, but we hypothesized that a transjugular approach would lead to limited interference of the catheter with the valve delivery system. It also benefited the imaging specialist given that the 3D ICE catheter requires minimal manipulation to obtain the images of the TV compared with the TEE probe, although it remained in the patient as well as backup. The transjugular approach also allowed the imager to manipulate both the 3D ICE catheter and TEE probe from the head of the bed and away from the valve delivery system, allowing the imager full control over all modalities (Figure 3). Ultimately the images obtained by 3D ICE allowed for a successful implantation of the EVOQUE valve. Perhaps it was ambitious to hope that this technical success would translate to meaningful clinical improvement in this critically ill patient.Figure 3Fluoroscopy of the Imaging Probe and CatheterFluoroscopic image demonstrating no interaction between the transesophageal echocardiography probe and 3-dimenisonal intracardiac echocardiography catheter with the EVOQUE valve delivery system. Fluoroscopy of the Imaging Probe and Catheter Fluoroscopic image demonstrating no interaction between the transesophageal echocardiography probe and 3-dimenisonal intracardiac echocardiography catheter with the EVOQUE valve delivery system. Conclusions Carcinoid syndrome is a disease that leads to significant thickening and retraction of the TV leaflets. Visualization of these leaflets can be impaired on TEE due to acoustic shadowing, allowing for advancements in imaging such as 3D ICE to play a major role in the procedural success. Transjugular 3D ICE has proven to be an effective and useful adjunctive imaging modality in cases of percutaneous TV replacement with poor visualization using TEE.Take-Home Messages•Patients undergoing TTVR who have limited visualization of the tricuspid valve leaflets on TEE can benefit from 3D ICE.•3D ICE catheter insertion via a transjugular approach for percutaneous TV replacement allows for the clear visualization of the TV leaflets with no interference with the valve delivery system. Take-Home Messages •Patients undergoing TTVR who have limited visualization of the tricuspid valve leaflets on TEE can benefit from 3D ICE.•3D ICE catheter insertion via a transjugular approach for percutaneous TV replacement allows for the clear visualization of the TV leaflets with no interference with the valve delivery system. •Patients undergoing TTVR who have limited visualization of the tricuspid valve leaflets on TEE can benefit from 3D ICE. Patients undergoing TTVR who have limited visualization of the tricuspid valve leaflets on TEE can benefit from 3D ICE. •3D ICE catheter insertion via a transjugular approach for percutaneous TV replacement allows for the clear visualization of the TV leaflets with no interference with the valve delivery system. 3D ICE catheter insertion via a transjugular approach for percutaneous TV replacement allows for the clear visualization of the TV leaflets with no interference with the valve delivery system. Funding support and author disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.